← Leaderboards
Zhiqiang Cao
Wayne State University
$3,013,472
Attributed
$3,013,472
Total exposure
2
Grants
2
Lead (contact PI)
Attributed= this PI's even-split share of every grant they're on (the fair, additive number). Exposure = full size of all those grants. They are the sole PI on all grants (the two match).
Funding over time
peak $1.3M · FY2016–22$2M$1.5M$1M$500K$0
'16
'17
'18
'19
'20
'21
'22
Funding mix
By agency
NIH$3,013,472 · 2
By mechanism
R01$1,700,444 · 1
DP2$1,313,028 · 1
Top collaborators
No co-investigators on record.
Most similar at Wayne State University
Same institution · by research overlap
- David Oupicky$10,225,505
- Federico Rabuffetti$1,504,826
- Guangzhao Mao$1,641,479
- Paul R Van Tassel$1,001,149
- Katherine Roth$150,684
Others in their field
Top investigators on “Insulin”
- Jeffrey P Krischer · University Of South Florida$605,714,892
- John M Lachin · George Washington University$153,440,346
- David M Nathan · Massachusetts Institute Of Technology$139,041,931
- Kathryn Hirst · Caritas St. Elizabeth'S Medical Center$108,827,660
- Mark A Magnuson · Vanderbilt University$79,749,111
- Jose A Luchsinger · Columbia University Health Sciences$71,267,462
Research focus
InsulinFormulationSuccessTechnologyDiabetic MouseAbsorptionEncapsulatedPerformanceAnimal ModelTissuesDiabetic RatBiological AvailabilityAdherenceBloodBile Acid TransporterDiabetic PatientDiffuseAmino Acid TransporterColloidsClinical TranslationBetaineDetergentsBacterial InfectionsDiabetic
Grant awards (5)
A Novel Oral Insulin Enabling Safe and Efficient Gastrointestinal Transport and Absorption$425,111
R01 · FY2022 · DK · contact PI
A Novel Oral Insulin Enabling Safe and Efficient Gastrointestinal Transport and Absorption$425,111
R01 · FY2021 · DK · contact PI
A Novel Oral Insulin Enabling Safe and Efficient Gastrointestinal Transport and Absorption$425,111
R01 · FY2020 · DK · contact PI
A Novel Oral Insulin Enabling Safe and Efficient Gastrointestinal Transport and Absorption$425,111
R01 · FY2019 · DK · contact PI
A Novel Formulation Enabling Longevity of Subcutaneous Insulin Infusion$1,313,028
DP2 · FY2016 · DK · contact PI